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Abstract
Dysbiosis of the microbiome on the airway mucosa leads to the development of
chronic inflammatory and allergic disorders. The aim of this study was to consider the
potential diagnostic criteria for allergic fungal rhinosinusitis (AFRS) and nonallergic
fungal rhinosinusitis (FRS), and the role of fungal presence in an environment for
the development of AFRS. In this study, 136 patients were divided into two groups:
patients with positive specific immunoglobulin E (sIgE) and fungal finding (AFRS group),
and patients with negative sIgE and positive fungal finding (FRS group). The study
design included: anamnesis data, sIgE, eosinophil count and skin-prick test, rhinology
and computerized tomography (CT) observation and mycological finding. Our results
showed: (i) the prevalence in Serbia is: AFRS 1.3%, FRS 2.8%; (ii) 30.4% patients with
sIgE+ had more often severe and recurrent chronic rhinosinusitis (CRS) (P = .005) and
the presence of polyps (P = .025); (iii) 46.4% patients with sIgE+ had positive fungi on
the sinonasal mucosa and were considered as AFRS; (iv) patients with AFRS had more
frequent asthma (P = .024) and chronicity of CRS >10 years (P = .000). The persistent
fungal presence and prolonged duration of CRS could be a silent threat for the pro-
gression of inflammation and development of FRS. Lavage with hypertonic-NaCl should
be included in the everyday hygiene routine in an effort to decrease fungal load and
antigenic exposure. The presence of allergological parameters and better response to
162 C© The Author 2017. Published by Oxford University Press on behalf of The International Society for Human and Animal
Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
D
ow
nloaded from
 https://academ
ic.oup.com
/m
m
y/article-abstract/56/2/162/3800175 by Belgrade U
niversity user on 28 June 2020
Barac et al. 163
corticosteroid therapy in AFRS patients should be considered as crucial diagnostic
criteria for AFRS.
Key words: allergic fungal rhinosinusitis, chronic rhinosinusitis, nasal polyps, fungi, sinonasal mucosa.
Abbreviations
AFRS, allergic fungal rhinosinusitis; FRS, fungal rhinosi-
nusitis; CT, computerized tomography; sIgE, specific im-
munoglobulin E; CRS, chronic rhinosinusitis; CRSsNP,
chronic rhinosinusitis without nasal polyps; CRSwNP,
chronic rhinosinusitis with nasal polyps; Ab, antibodies;
BA, blood agar; SDA, Saburoad dextrose agar; PDA, potato
dextrose agar; FESS, functional endoscopic surgery of si-
nuses; ISNS-F, induced sinonasal secretion flow; ISNS-
A, aspiration of induced sinonasal secretion; reFESS, re-
peated functional endoscopic surgery of sinuses; EDTA,
ethylene-diamine-tetra-acetic acid; ENT, ear, nose and
throat; HS, home sample; F+, positive fungal finding; EFRS,
eosinophilic fungal rhinosinusitis; SPT, skin prick test.
Introduction
The humanmycobiome, consisting of a diverse collection of
fungi, is one of the new perspectives in the research of upper
airway diseases. Resident mycobiome interacts extensively
with immune cells and epithelium of the airway mucosal
surfaces. Dysbiosis of the microbiome on airway mucosa
and pathogen-host interaction leads to the development of
chronic inflammatory and allergic disorders.1 Many stud-
ies have shown that inflammation of sinonasal mucosa is
associated with enrichment of specific sinus pathogens that
leads to the development of chronic rhinosinusitis (CRS).1,2
Researchers reported that microbiome of sinonasal mucosa
has a major role in regulating immune cells that are of rele-
vance for allergic diseases.3 However, there are many gaps
in knowledge about the role of fungi modulating local im-
mune response on sinonasal mucosa in these patients. After
birth, a child is exposed to fungi present in the environment.
After 4 months from birth, fungi can be obtained as normal
content from almost everyone’s nasal mucosa.3 On the con-
trary, there are many reports of sinonasal disease caused by
the presence of fungi, termed fungal rhinosinusitis (FRS).4,5
Although there are many controversies in the classifica-
tion of FRS, it is well known that it encompasses a diverse
spectrum of disease depending on the immune status of
the host. Asymptomatic fungal colonization of sinonasal
mucosa is common and requires no treatment, while aller-
gic fungal rhinosinusitis (AFRS) represents a huge challenge
for diagnosis and treatment. AFRS is a noninvasive form of
FRS with a prevalence of 6–9%, often co-localized with
nasal polyps (NP), type immunoglobulin E (IgE)-mediated
hypersensitivity, and presence of eosinophilic mucin.4,5,6
Diagnosis of AFRS is controversial and requires multiple
tests for measurement of moulds, specific IgE antibodies
(Ab), eosinophil count in blood/tissue, and mycological
confirmation of fungal presence.7 Treatment of AFRS dif-
fers from the one for FRS; hence the precise definition of
AFRS is crucial.6,7
The objective of this study was to consider potential dif-
ferential diagnostic criteria for AFRS and non-mould-
allergic FRS, a pathway of AFRS development, and the role
of fungi present in the environment for the development of
AFRS.
Methods
Study population
This prospective clinical case-series study was conducted
at the Clinic for Allergology and Immunology, Clinical
Centre of Serbia and Institute of Microbiology, Faculty of
Medicine, University of Belgrade, Serbia, from March 1 to
August 1, 2014. The study was approved by the Ethical
committee of Clinical Center of Serbia (5030/5) and the
Ethical committee of Faculty of Medicine University of Bel-
grade (29/VI-3).
CRS is clinically defined by three criteria:
1.At least two of following symptoms: nasal block-
age/obstruction/congestion, nasal discharge (anterior/
posterior nasal drip), facial pain/pressure, reduction or
loss of smell for ≥12 weeks.
2.Endoscopic finding of nasal polyps and/or mucopurulent
discharge and/or edema/mucosal obstruction.
3.Computerized tomography (CT) finding: mucosal
changes within ostiomeatal complex without nasal
polyps (CRSsNP) or with nasal polyps (CRSwNP).8
Patients with CRS were included in the study if they ful-
filled inclusion criteria: (1) >16 years; (2) symptoms ≥12
weeks; (3) no treatment with systemic corticosteroids over
last 7 days and local corticosteroids for 3 days before in-
clusion; and (4) absence of invasive fungal infection (IFI)
(screened by serology testing of anti-Aspergillus and anti-
Candida immunoglobulin M [IgM] and immunoglobulin G
[IgG] Ab, as well as the concentration of galactomannan
and mannan in patients’ sera).
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Patients were divided into two groups depending on the
class of mould mix specific IgE (sIgE) in sera. Patients with
mould-mix sIgE Ab classes 1–6 belonged to group sIgE+,
while patients with mould-mix specific IgE Ab class 0 be-
longed to group sIgE−. After mycological analyses, patients
were divided into two groups: patients with positive sIgE
and presence of fungi in nasal mucosa (group A/AFRS) and
patients with negative sIgE, but the presence of fungi in
nasal mucosa (group B/non-moulds-allergic FRS).
AFRS is defined as a presence of the following: (i)
type I (IgE) hypersensitivity reaction to moulds (serology),
(ii) hyperattenuating signal density visualized by CT scan
(“double density” sign), (iii) presence of eosinophilic mu-
cus, and (iv) presence of the fungi in sinus content.9
Study design
Study design included: (1) collection of patient’s demo-
graphics and history data including number of previous
functional endoscopic surgery of sinuses (FESS), duration
of CRS, previous use of local corticosteroids during three
months, co-morbidity data; (2) atopic/allergic examination
(mould-mix sIgE in serum, total IgE in serum, absolute
eosinophil count in blood and skin prick test/SPT on in-
halant allergens); (3) rhinoscopic inspection and evalua-
tion of rhinoscopic score; (4) measurements and evaluation
of CT score for fulfillment and opacification of maxillary
sinuses; (5) microbiological analysis of induced sinonasal
secretion flow (ISNS-F) and induced aspirate; and (6) culti-
vation of air samples from patients’ homes (bedrooms).
Allergy examination
Mould-mix specific IgE Ab
Serological measurement of the level of sIgE was con-
ducted by fluoroenzyme immunoassay using ImmunoCAP-
100 (Phadia AB, Uppsala, Sweden). The sIgE was related to
mould-mix (Mx1) comprised of Penicillium chrysogenum
(m1), Cladosporium herbarum (m2), Aspergillus fumigatus
(m3), and Alternaria alternata (m6). A. alternata allergen
contained rAlt a1, while A. fumigatus contained rAsp f1,
rAsp f2, rAsp f3, rAsp f4 and rAsp f6 antigen components.
Test results were reported as positive or negative. A cut-
off value of 0.35 kUA/l was considered as positive. Values
≥0.35 kUA/L indicated sIgE to one or more of allergens
from mould-mix.10
Total serum IgE
A concentration of total IgE Ab in serum was measured by
enzyme-linked immunosorbent assay (ELISA; Euroimmun
AG, Germany). Results were interpreted as follows: (i) neg-
ative (<100 kU/L), (ii) low positive (100–500 kU/l) and (iii)
high positive (≥500 kU/l).
Eosinophil count
The blood sample was taken before SPT and put into the
tube containing ethylene-diamine-tetra acetic acid (EDTA).
Eosinophil counting was performed with Fuchs-Rosenthal
counting chamber.11 Results <350 mm3 were considered
as negative.
Skin prick testing (SPT)
The panel of SPT extracts comprised a variety of al-
lergens: epithelia (cat, dog, horse), pollens (Betula veru-
cosa, Olea europea, Cupressus arizonica, Phleum pratense,
Ambrosia artemisia, Artemisia vulgaris), dust mite (Der-
matophagoides farinae, D. pteronyssinus), and fungi (A.
alternata, Aspergillus flavus, C. herbarum, Penicillium
notatum) (ALK-abello, Hørsholm, Denmark). Histamine
(10 mg/ml) was used as positive control, and diluent (saline
in 50% glycerol) was used as negative control. Wheal reac-
tion was measured as the mean value of longest diameter
and diameter perpendicular to it. Reactions with diameter
≥3 mm were considered as positive.
Rhinoscopy
All patients were examined by ear, nose, and throat (ENT)
specialist at Clinic forOtorhinolaryngology, Clinical Centre
of Serbia, Belgrade, Serbia. The ENT specialist performed
rhinoscopy with standard rigid rhinoscope and estimated
Lund-Mackay score (LMS) by measuring a presence of fol-
lowing parameters: edema, discharge, and presence of NP.
Each parameter was scored as 0-absent, 1-mild, 2-severe,
and 3-only for parameter “NP” if completely obstructing
nose. All parameters were noted separately for left/right
side, and all were summed up from 0 to 14.12 Rhinological
scoring index for all observed parameters was suggested as
follow: (i) 0–4: “0 index” and mild CRS, (ii) 5–9: “1 index”
and moderate CRS and (iii) 10–14: “2 index” and severe
CRS.
CT imaging
CT visualization of paranasal sinuses was done in the De-
partment of Radiology, Faculty of Dental Medicine, Uni-
versity of Belgrade, Serbia. To determine the stage of CRS
we established “CT-scoring index” measured by fulfilment
of maxillary sinus in one section on each side separately:
(i) fulfilment 0–33% “score 0”, (ii) 33–66% “score 1” and
(iii) 66–100% “score 2”. Sum of scores from both sides
gave cumulative index and determinate the grade of CRS:
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(i) 0 score as “0 index” and mild CRS, (ii) 1–2 scores as “1
index” and moderate CRS, and (iii) 3–4 scores as “2 index”
and severe CRS.
Microbiology
Sinonasal secretion flow and aspiration
Before sampling ISNS, nasal cavities were pretreated with
cotton swabs in the aim to decrease the possibility of con-
tamination and to increase the probability of sampling
proper content directly from sinuses. Patients were sprayed
by the sterilized hypertonic 7% NaCl solution into each
nostril and forcefully exhaled ISNS-F through nostrils di-
rectly on blood agar (BA) and Saburoad dextrose agar
(SDA), separately for each nostril. Afterward, each patient
did the inhalation by PARI-SINUS nebulizer with 5 ml of
hypertonic-NaCl solution for 10 minutes in the quadruped
position (PARI, Starnberg, Germany). Quadruped position
facilitates drainage of the content from paranasal sinuses.13
After the inhalation, mucin was collected from the sinuses
by aspiration in a supine position with head tilted back-
ward at a 30◦ angle. ISNS-A sampling was done by use of
the mucus extractor (ULTRAMED, Asyut, Egypt), and the
obtained sample was additionally processed in ultrasound
cleaner (BlueWave Ultrasonic, Davenport, IA, USA). ISNS-
F and processed ISNS-A were incubated on SDA at 25◦C
for 7 days.
The patient was considered as fungal positive if: (i) ISNS-
F was positive twice within an interval of 7 days with an
isolation of the same fungi in both samples or (ii) ISNS-A
was positive once.
Air sampling
Patients were asked to leave open petri dishwith potato dex-
trose agar (PDA) for 1 h at room temperature in their bed-
rooms. Petri dishes containing air-samples were fixed with
parafilm (Sigma-Aldrich, USA) and deposited at the labora-
tory for further analysis. Plates were incubated at 25◦C for
7 days. Identification of fungi was based on macroscopic
and microscopic characteristics using standard mycological
methods.14
Statistical analysis
Descriptive and inferential statistical analyses were used
for evaluation of data using Statistical Package for Social
Science (SPSS 17.0) (SPSS, Chicago, IL, USA). Data were
expressed as mean±standard deviation (SD) and counts or
percentages, where appropriate. Mann–Whitney test was
used for nonparametric data, and χ2 test was used for cate-
gorical variables. All differences were considered significant
at P < .05.
Results
Clinical characteristics and sociodemographic
data of CRS patients
Out of 985 consecutive outpatients with any allergic dis-
ease examined during 5 months, 136 patients (13.8%) had
clinically confirmed the diagnosis of CRS by criteria pro-
posed by the European Position Paper onRhinosinusitis and
Nasal Polyps.8 Out of 136 consecutive patients with CRS,
24 did not provide consent, while 112 signed written con-
sent. Mean age of 112 patients was 38.38 ± 13.32 (range,
16–66) with an equal frequency of sex. Mean duration of
CRS was 13.77 ± 10.6 years (range, 2–40 years). Recalci-
trant NP with repeated FESS (reFESS) was found in 44.6%
patients with CRS. About 51.8% of patients had severe
CRS estimated by rhinological score and 36.6% measured
by CT score (Suppl. 1).
Relationship between clinical characteristics of
CRS patients with and without positive moulds
sIgE
Out of 112 CRS patients, 34 (30.4%) had positive moulds
sIgE and represented sIgE+ group, while 78/112 (69.6%)
patients represented sIgE− group. By comparing differ-
ence between sIgE− and sIgE+ groups, we found that pa-
tients with positive moulds sIgE had more often reFESS
(67.6% vs. 34.6%, P = .005) and presence of NP
(34.9% vs. 23.1%, probability value/P = .025), and more
severe forms of CRS measured by Rhinological (76.5% vs.
41%, P = .02) and CT (47% vs. 32.1%, P = .042) indexes
(Suppl. 1).
Relationship of clinical characteristics of CRS
patients with positive moulds sIgE and positive
fungal finding (group A) and with negative
moulds sIgE and positive fungal finding (group B)
Mycological analyses revealed positive fungal finding (F+)
in 28/112 ISNS-F/ISNS-A patients. Out of 28 F+ patients,
13 (46.4%) had positive moulds sIgE (group A, AFRS). Pa-
tients with F+ and negative moulds sIgE Ab (15/28, 53.6%)
were considered as non-mould-allergic FRS (group B, non-
mould-allergic FRS) (Table 1). Patients with an absence
of fungi on nasal mucosa and without mould hypersen-
sitivity were classified as group C (84/112, 75%). It was
found that frequency of AFRS was 1.3%, while the fre-
quency of non-mould-allergic FRS was 2.8%, in the group
of patients with CRS. Group A had an almost equal distri-
bution of sex with a male to female ratio 1.2:1 and mean
age 32.23 ± 13.25. More patients from group A than from
group B (76.9% vs. 33.3% respectively, P = .021) had
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Table 1. Relationship of clinical characteristics of patients with positive moulds sIgE Ab and positive fungal finding (A group,
n = 13) and negative moulds sIgE Ab and positive fungal finding (B group, n = 15).
Group n (%)
B A
Variables n = 15 (53.6) n = 13 (46.4) p
Sex 0.139
M 12 (80) 7 (53.9)
Age (mean ± SD) 0.535
39.53 ± 13.06 32.23 ± 13.25
Subjective improvement of symptoms after corticosteroid Th ∗0.021
Yes 5 (33.3) 10 (76.9)
NP 0.705
Yes 7 (46.7) 7 (53.9)
Previous FESS > 1 (reFESS) 0.630
Yes 13 (86.7) 12 (92.3)
Asthma ∗0.024
Yes 4 (26.7) 9 (69.2)
Duration of CRS (years) ∗0.000
<5 7 (46.7) 0 (0)
5-10 6 (40) 0 (0)
10-20 1 (6.7) 5 (38.5)
>20 1 (6.7) 8 (61.5)
Rinoscopic score for objective assessment of CRS 0.637
Mild 1 (6.7) 0 (0)
Moderate 1 (6.7) 1 (7.7)
Severe 13 (86.7) 12 (92.3)
CT score for objective assessment of CRS 0.889
Mild 1 (6.7) 1 (7.7)
Moderate 1 (6.7) 1 (7.7)
Severe 12 (80) 11 (84.6)
Absolute eosinophils count (mm3) ∗0.006
Positive (>350) 5 (33.3) 11 (84.6)
Absolute eosinophils count (mean ± SD) 0.970
442.40 ± 455.794 426.0 ± 228.125
Total IgE Ab (kU/ml) ∗0.021
Positive (>100) 5 (33.3) 10 (76.9)
Total IgE Ab (mean ± SD) ∗∗0.05
392.0 ± 589.803 685.38 ± 695.121
SPT (inhalant allergens) 0.194
Positive 7 (46.7) 3 (23.1)
SPT dust mite ∗0.008
Positive 2 (13.3) 8 (61.5)
SPT animal epithelia 0.750
Positive 3 (20) 2 (15.4)
SPT pollens 0.840
Positive 11 (73.3) 9 (69.2)
SPT moulds
Positive 7 (46.7) 3 (23.1) 0.194
Alternaria alternata 0 (0) 3 (23.1) ∗0.049
Penicillium notatum 5 (33.3) 0 (0) ∗0.022
Cladosporium herbarum 2 (13.3) 1 (7.7) 0.630
Aspergillus fumigatus 6 (40) 1 (7.7) ∗0.049
∗ According to Chi-square test, p < 0.05, ∗∗According to Mann–Whitney U test, P < 0.05.
Abbreviations: Ab, antibody; CRS, chronic rhinosinusitis, CT, computerized tomography; Eo, eosinophiles; FESS, functional endoscopic surgery of sinuses; NP,
nasal polyposis; SD, standard deviation; sIgE, specific Immunoglobulin E; SPT, skin prick test; Th, therapy.
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Figure 1. Distribution of fungal and bacteria species isolated from sinonasal mucosa of patients from groups A and B: predomination of S. aureus,
A. fumigatus, Penicillium sp. and A. alternate in the group A and S. aureus, Penicillium sp. and Cladosporium sp. in the group B.
improvement of symptoms after 3 months of local corti-
costeroid therapy. Asthma was detected more frequent in
group A than in group B (69.2% vs. 26.7% respectively,
P = .024). Duration of CRS more than 10 years, was more
frequent in group A than in group B (100% vs. 13.3%
respectively, P = .000) (Table 1).
Allergological parameters of patients
Patients from group A had more often eosinophils count
≥350 (84.6% vs. 33.3%, respectively, P = .006) and higher
mean level of total IgE Ab than patients from group B
(685.38 ± 695.121 vs. 392.0 ± 589.803, respectively,
P = .05). There were no differences in the sum of results
of SPT with inhalant allergens between groups, but indi-
vidually, patients from group A were more often positive
to dust mite allergens (D. pteronyssinus and D. farinae)
than non-mould-allergic FRS patients (61.5% vs. 13.3%,
respectively, P = .008). There was also statistically signifi-
cant difference between groups in predominant mould SPT
allergens: patients from group A had the most common
hypersensitive reaction to A. alternata (P = .049), while
patients from group B had the most common hypersensi-
tive reaction to P. notatum (P = .022) and A. fumigatus
(P = .049) (Table 1).
Distribution of fungal and bacteria species
isolated from sinonasal mucosa of patients
The most common fungal species isolated from ISNS-
F/ISNS-A of group A was A. fumigatus isolated in 28.6%
(10/35) cases, followed by Penicillium sp. 20% (7/35);
while Penicillium sp. (6/27; 22.2%) followed by Cladospo-
rium sp. (5/27; 18.5%) were the most common isolates
in group B. Staphylococcus aureus was commonly isolated
from both groups; 60% in ISNS-F/ISNS-A of group A and
45.5% of group B (Fig. 1). There was no relationship be-
tween the most common sensitized fungi and the most com-
mon cultured fungi nor in group A neither in group B.
Biodiversity of fungi in air samples obtained from
homes of patients
Out of all fungal isolates (n = 225) from the air samples
obtained from the homes of patients with CRS, 41 isolates
were from the home samples (HS) of group A, 24 from
HS of group B, and 159 from the HS of non-FRS patients
(Fig. 2). The most predominant species was A. niger iso-
lated in 57% of HS, followed by Penicillium sp. isolated in
26% of HS (Fig. 2). There was an overlap in fungal isolates
from ISNS-F/ISNS-A and air sample in the case of only one
patient (Table 2).
Discussion
This extensive study provided a comparison of CRS cases
due to fungal allergies compared to those without al-
lergy. Our analyses found: (i) patients with CRS and pos-
itive mould sIgE (30.4%) had more often repeated FESS
intervention (P = .005), presence of NP (P = .025), and
more severe CRS form; (ii) in our study, frequency of AFRS
was 1.3%, while frequency of non-mould-allergic FRS was
2.8%; (iii) in patients with AFRS following parameters were
more frequently present: asthma (P = .024), longer dura-
tion of CRS (>10 years) (P = 0) and positive response to
corticosteroid therapy (P = .021).
Given ubiquitous nature of fungi, exposure is unavoid-
able, but it is not yet known which fungi are able to
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Figure 2. Fungal biodiversity in environment: A. niger, Penicillium sp. and Curvularia were the most common isolates obtained from the home’s air
samples from all groups.
cause allergies and chronic airway inflammation.15 There
is growing necessity to show which fungi are prevalent in
patients’ environments and to compare them with fungi
prevalent at sinonasal mucosa of FRS patients.15,16 Com-
mon fungal species isolated from the sinonasal cavity of
AFRS patients in our study were A. fumigatus (28.6%) and
Penicillium sp. (20%), while the most common isolated
bacteria was S. aureus (60%). Few studies claim the strong
association between S. aureus superantigens and AFRS.17,18
Additionally, S. aureus colonization was significantly more
prevalent in AFRS in comparison with nonallergic FRS.19
S. aureus superantigen-induced immune response leads to
modulation of a severity of eosinophils inflammation20 and
correlates with total IgE Ab levels in AFRS patients, intimat-
ing relationship between bacterial colonization and allergic
hypersensitivity.21 In meta-analyses of Jing Ou et al., it was
claimed that S. aureus superantigen may be the risk factor
for the chronicity and severity of CRS that leads to modula-
tion of local immune response resulting in the development
of AFRS.17,21
The presence of fungus in culture does not establish nor
eliminate the diagnosis of AFRS, as there is the question
if an isolated fungus is a causative agent or contaminant
from air.22 Buzina et al. showed that proportion of indi-
viduals positive for fungal growth was exactly the same
(91.3%) by flushing the noses of CRS patients and healthy
volunteers.15 Study results of Ponikau et al., who used the
same sampling technique, showed the slightly higher result
(96% and 100% positive for patients and controls, respec-
tively).25 Other studies reported comparatively lower rate
of isolation: 80% (Perez-Jaffe et al. 1997), 61.5%22 and
48.6%.26 Though we applied improved technique, fungal
detection in the sinuses was only 25% of CRS. It is difficult
to explain such low isolation rate in our study, but geo-
graphical location of study and environment factors may
play an important role in fungal colonization of nasal mu-
cosa.
As fungi are continually present as allergens on sinonasal
mucosa, lavage with hypertonic NaCl may help to decrease
fungal load and antigenic exposure. Our results showed
that longer duration of CRS (>10 years) leads to the devel-
opment of AFRS. This finding could be explained by modu-
lated local immune response due to the long-lasting inflam-
mation and continual presence of fungi as triggers on the
sinonasal mucosa. We propose that duration of CRS should
be crucial for progression from local to the systemic aller-
gic reaction, which is manifested as the finding of positive
moulds sIgE and the higher number of eosinophils. In re-
lated studies, authors found clusters of eosinophils grouped
around fungal elements in nasal mucus and concluded that
fungi act as triggers for an eosinophil-mediated immune re-
sponse.22,23 In our study, patients with AFRS had higher
eosinophil count (≥350 mm3) compared to patients with
non-mould-allergic FRS, which supports the hypothesis of
eosinophil’s important role in pathogenesis and diagnosis
of AFRS.
Though type I hypersensitivity and presence of fungi
in allergic mucin are considered as a hallmark of AFRS,
Ponikau et al. showed that fungi in mucin may be present
in many cases of CRS without the presence of type I hy-
persensitivity and coined term “eosinophilic fungal rhinos-
inusitis” (EFRS).25 Their hypothesis was further supported
by subsequent studies.4,5,8 On the other hand, the presence
of other allergological parameters, such as mould sIgE Ab,
but without the presence of any fungal hyphae in mucin,
has been noted in the group of patients with CRS.27 In our
study, 46.4% of patients with positive anti-moulds sIgE had
the positive fungal finding on sinonasal mucosa and could
be considered as AFRS. Differential diagnostic criteria for
AFRS evolved from our study are: (i) presence of specific
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Table 2. Comparison of fungal isolates from sinonasal and air samples from patients from groups A and B.
Patients (Pt) Sinonasal isolate Air sample isolate
Group A n = 35 n = 41
Group A Pt 1 Fusarium sp.; Penicillium sp. A. niger; Curvularia lunata; A. alternata
Pt 2∗ A. niger; Rhizopus sp.; A. fumi gatus Penicillium sp.; A. alternata; A. fumigatus; A. niger
Pt 3 A. flavus; Penicillium sp.; A. fumigatus A. niger; Curvularia lunata
Pt 4 Cladosporium sp.; A. alternata; A. fumigatus A. niger; A. glaucus; Curvularia lunata
Pt 5 Fusarium sp. A. niger; Penicillium sp.
Pt 6 A. niger; Penicillium sp.; A. fumigatus Curvularia lunata; A. alternata;
Pt 7 A. flavus; Penicillium sp.; A. fumigatus A. niger; Fusarium sp.; A. glaucus
Pt 8 Rhizopus sp.; Penicillium sp.; A. fumigatus A. niger; Fusarium sp.
Pt 9 A. alternate A. niger; A. flavus
Pt 10 Cladosporium sp.; A. alternata; A. fumigatus A. niger; Chrysosporium sp.; Curvularia lunata
Pt 11 A. alternata; A. fumigatus A. niger; A. flavus
Pt 12 A. flavus; Penicillium sp.; A. fumigatus A. niger; Curvularia lunata; A. alternata
Pt 13 Cladosporium sp.; Penicillium sp.; A. fumigatus A. niger; A. flavus
Pt 14 Rhizopus sp. Curvularia lunata; A. alternata A. fumigatus; A. niger
Pt 15 A. alternate Fusarium sp.; Chrysosporium sp.;
A. glaucus; Curvularia lunata
Group B n = 27 n = 24
Group B Pt 1 Fusarium sp. A. niger; Penicillium sp.
Pt 2 Rhizopus sp. Curvularia lunata
Pt 3 Cladosporium sp.; A. alternata A. niger; Penicillium sp.
Pt 4 A. niger; Rhizopus sp. Penicillium sp.
Pt 5 A. flavus; Cladosporium sp. A. niger; Penicillium sp.
Pt 6 Rhizopus sp.; Penicillium sp. Curvularia lunata
Pt 7 Cladosporium sp.; Penicillium sp.; A. fumigatus A. niger; Rhyzopus sp.
Pt 8 A. flavus; Penicillium sp. Fusarium sp.; A. nidulans
Pt 9 A. flavus; Cladosporium sp. Penicillium sp.; A. versicolor
Pt 10 Rhizopus sp.; Penicillium sp A. niger; A. nidulans
Pt 11 Cladosporium sp.; A. alternata; Penicillium sp. A. flavus; Rhyzopus sp.; A. fumigatus
Pt 12 A. alternata; A. fumigatus Penicillium sp.; A. glaucus
Pt 13 A. niger; Penicillium sp.; A. fumigatus A. flavus; A. versicolor
∗Patient with same fungal isolate from sinonasal and air samples.
allergological indicators (sIgE, eosinophils, or SPT), (ii)
presence of fungi in sinonasal aspirate, and (iii) positive
response to corticosteroid therapy.
We postulated that pathophysiology of AFRS is sim-
ilar to the allergic fungal bronchopulmonary disease.
The atopic host is exposed to the fungi via normal nasal
respiration, which provides initial antigenic stimulation.22
Accumulation of allergic mucin obstructs involved sinuses
and creates an ideal environment for proliferation of fungi
inhaled from the air.5,23 Predominant fungal species in
air samples taken from homes of CRS patients was A.
niger (57%), followed by Penicillium sp. (26%), and we
found common positive reactions on SPT in AFRS group
were to allergens of Alternaria, Aspergillus, and Penicil-
lium. The presence of different species in outdoor air de-
pends on geographic location as is shown previously, and
discrepancies in our study, between isolated species in the
sinuses and isolated species from the air samples, could be
because of regional differences in the etiologic fungi, as well
as because cross-reactivity of allergens derived from com-
mon airborne fungi that could also play important role in
atopic patients.5,23,28 Avoidance of places with the fungal
overload of air may help patients with AFRS in the preven-
tion of possible sharing of airborne fungal epitopes.
Investigators from the Mayo Clinic hypothesized that
nearly all cases of CRS were driven by the host responses to
common airborne fungal elements.16,29,28 Using specialized
detection techniques, fungal microorganisms were identi-
fied in 100% sinonasal cavities of both CRS and healthy
control patients.15 These findings were later combined with
in vitro studies demonstrating hyperreactivity of periph-
eral blood mononuclear cells to antigens of Alternaria.17
This response was obtained in CRS patients but was ab-
sent in controls and thus was proposed to reflect an im-
munologic sensitization to fungal antigens independent of
atopy.19 Later studies demonstrated that nasal mucus from
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patients with CRS triggered eosinophil migration18 and
that 60-kDa component of Alternaria elicited eosinophil
degranulation.29 In summary,Alternaria and possibly other
fungi were proposed to serve a dual role: first, inhaled
and processed fungal proteins were presented to sensitize
T-cells triggering cytokine response that activated and at-
tracted eosinophils to the mucosal surface. Second, these
eosinophils then targeted fungi as an aberrant host defense
response, with degranulation and collateral tissue damage
mediating symptoms of CRS. Activated eosinophils, ob-
tained from CRS patients, were shown on videos attack-
ing fungi, providing persuasive visual evidence to support
this hypothesis.16,30 Lastly, fungal cell walls contain chitin,
which has been shown to induce the Th2 response in some
human and animal models, although any role in CRS re-
mains unclear.31–34 Fungi also likely play the key role in
classic AFRS.33
The mechanism by which airborne fungi turn from ‘nor-
mal flora’ into triggers of inflammatory reactions, resulting
in FRS, is currently under investigation at several research
centers. It is shown in our study that patients with AFRS
have similar symptoms as patients with non-mould-allergic
FRS, but the statistically significant better response on cor-
ticosteroid therapy. This result would encourage in diag-
nosing of AFRS cases.
Fungal species are ubiquitously present in an environ-
ment, as well as in human sinonasal tract as normal con-
tent. We propose that persistent presence of fungi and pro-
longed duration of CRS should be the silent threat for
progression of inflammation and development of FRS. As
the fungi trigged enhancement of IgE Ab and eosinophils,
lavage with hypertonic NaCl should be included in every-
day hygiene routine in an effort to decrease fungal load and
antigenic exposure. The presence of allergological parame-
ters and better response to corticosteroid therapy in AFRS
patients should be crucial diagnostic criteria for AFRS. Fur-
ther studies are required to precise define and resolve diag-
nosis of non-mould-allergic FRS.
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